Immediate Impact
55 standout
Citing Papers
Pancreatic cancer
2025 Standout
Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress
2024 Standout
Works of Eirik Søfteland being referenced
Pancreatic exocrine insufficiency in diabetes mellitus - prevalence and characteristics
2019
Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Eirik Søfteland | 126 | 246 | 260 | 185 | 51 | 701 | |
| Kenji Yogo | 152 | 131 | 243 | 49 | 51 | 825 | |
| O. Brandsborg | 133 | 210 | 132 | 101 | 48 | 667 | |
| Hanaa S. Sallam | 84 | 227 | 151 | 59 | 37 | 785 | |
| Hani Rashed | 90 | 337 | 189 | 24 | 47 | 694 | |
| Gerrit H. de Groot | 58 | 116 | 136 | 75 | 23 | 646 | |
| Björn Biber | 147 | 49 | 213 | 24 | 49 | 824 | |
| L.‐T. Ho | 56 | 34 | 164 | 243 | 31 | 763 | |
| F. Marcianò | 268 | 33 | 128 | 173 | 24 | 784 | |
| Christoph Maier | 199 | 41 | 104 | 101 | 48 | 669 | |
| Ole Eshøj | 62 | 34 | 321 | 153 | 18 | 727 |
All Works
Login with ORCID to disown or claim papers
Loading papers...